Supreme Court to Rule on Generic Drugs -- Key Interviews Available via Conte Foundation

Supreme Court to Rule on Generic Drugs -- Key Interviews Available via Conte Foundation The U.S. Supreme Court is expected to rule shortly on whether generic drug companies must adequately warn doctors about new or revised risks to patients who have taken the drugs they make. (Pliva v Mensing No. 09-993, Actavis v Mensing No.08-3850 and Actavis v Demahy No. 09-1501) All three cases involve patients who took metoclopramide, the generic version of the brand-name drug Reglan. The Conte Foundation will arrange interviews with the attorney for Demahy, a metoclopramide victim or the Foundation’s
Contributor
PR Web
PR Web
Lanham, Maryland
Law Marketing
1.800.345.5572
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations
Download

Related Documents in PR Web
MCLE Sales

Categories